AKT1 and neoplasm: Our results are in keeping with previous reports indicating that inhibitors of the PI3K/Akt pathway can have effects of tumour vascularity (Rubin et al, 1996; Gupta et al, 2005; Fokas et al, 2012; Kuger et al, 2013).